Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase III trial of AG10 in ATTR polyneuropathy

Trial Profile

A phase III trial of AG10 in ATTR polyneuropathy

Planning
Phase of Trial: Phase III

Latest Information Update: 17 Sep 2018

At a glance

  • Drugs AG 10 (Primary)
  • Indications Amyloid polyneuropathy
  • Focus Therapeutic Use
  • Sponsors Eidos Therapeutics
  • Most Recent Events

    • 17 Sep 2018 According to an Eidos Therapeutics media release, the company plans to initiate this study in the first half of 2019.
    • 16 Aug 2018 New trial record
    • 07 Aug 2018 According to an Eidos Therapeutics media release, the company plans to initiate this trial in 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top